Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Journal of Cancer Research and Therapeutics
|
September 4, 2025
Effect of radical radiotherapy dose on the prognosis of limited-stage thoracic small cell carcinoma of the esophagus: A multicenter retrospective trial from China (CHiSCEC)
Zhanyuan Li, Qi Zhang, Qifeng Wang, et al.
BMC Cancer
|
May 1, 2019
A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol
Chen Li, Xiaomin Wang, Xin Wang, et al.
BMC Cancer
|
May 25, 2019
Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol
Chen Li, Xiaomin Wang, Xin Wang, et al.
Radiation Oncology (London, England)
|
July 29, 2022
Dose escalation based on <sup>18</sup>F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)
Hongcheng Zhu, Qiufang Liu, Hao Xu, et al.
Angewandte Chemie (International Ed. in English)
|
June 25, 2025
Copper-Tailored Molybdenum-Nickel Catalyst Boosts Hydrogen Oxidation and Suppresses Parasitic Oxygen Reduction for Durable Fuel Cells
Lei Zhu, Xiao-Long Zhang, Yu Yang, et al.
Translational Cancer Research
|
February 4, 2022
Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A)
Lan Wang, Xin Wang, Xuejiao Ren, et al.
International Immunopharmacology
|
October 14, 2025
Impact of consolidation immunotherapy after definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: a real-world multicenter study
Nuo Yu, Cheng Chen, Xiaomin Wang, et al.
Cancer Biology & Therapy
|
May 14, 2025
Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world study
Xiongtao Yang, Xiaomin Wang, Qin Xiao, et al.
Frontiers in Oncology
|
October 30, 2020
Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study
Qin Qin, Xiaolin Ge, Xin Wang, et al.
Journal of the National Cancer Center
|
July 22, 2024
Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016
Xin Wang, Fei Liang, Xiaomin Wang, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Journal of Cancer Research and Therapeutics
|
September 4, 2025
Effect of radical radiotherapy dose on the prognosis of limited-stage thoracic small cell carcinoma of the esophagus: A multicenter retrospective trial from China (CHiSCEC)
Zhanyuan Li, Qi Zhang, Qifeng Wang, et al.
BMC Cancer
|
May 1, 2019
A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol
Chen Li, Xiaomin Wang, Xin Wang, et al.
BMC Cancer
|
May 25, 2019
Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol
Chen Li, Xiaomin Wang, Xin Wang, et al.
Radiation Oncology (London, England)
|
July 29, 2022
Dose escalation based on <sup>18</sup>F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)
Hongcheng Zhu, Qiufang Liu, Hao Xu, et al.
Angewandte Chemie (International Ed. in English)
|
June 25, 2025
Copper-Tailored Molybdenum-Nickel Catalyst Boosts Hydrogen Oxidation and Suppresses Parasitic Oxygen Reduction for Durable Fuel Cells
Lei Zhu, Xiao-Long Zhang, Yu Yang, et al.
Translational Cancer Research
|
February 4, 2022
Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A)
Lan Wang, Xin Wang, Xuejiao Ren, et al.
International Immunopharmacology
|
October 14, 2025
Impact of consolidation immunotherapy after definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: a real-world multicenter study
Nuo Yu, Cheng Chen, Xiaomin Wang, et al.
Cancer Biology & Therapy
|
May 14, 2025
Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world study
Xiongtao Yang, Xiaomin Wang, Qin Xiao, et al.
Frontiers in Oncology
|
October 30, 2020
Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study
Qin Qin, Xiaolin Ge, Xin Wang, et al.
Journal of the National Cancer Center
|
July 22, 2024
Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016
Xin Wang, Fei Liang, Xiaomin Wang, et al.
Page
of 10